Enfiera 100mg (Rituximab Vials) 100mg/10ml

Enfiera 100mg (Rituximab) is a monoclonal antibody infusion used for autoimmune and cancer therapies. This 100mg/10ml vial is stored at 2-8°C and is manufactured by Zydus Healthcare in India. A sterile prescription medication for targeted immune modulation.

Strength

100mg/10ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

ZYDUS HEALTHCARE

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Rituximab, the active ingredient in Enfiera 100mg, is used to treat certain autoimmune conditions like rheumatoid arthritis and vasculitis. It is also prescribed for specific blood cancers including non-Hodgkin lymphoma and chronic lymphocytic leukemia. Patients often ask what is rituximab used for in these broad therapeutic categories.

Side Effects

Enfiera 100mg works by targeting and reducing specific immune cells in the body. Patients may notice gradual improvement in symptoms related to their condition over time. The medication is administered under medical supervision to monitor responses and manage potential reactions.

Precautions & Warnings

Store Enfiera 100mg vials refrigerated between 2-8°C and protect from light. Do not freeze or shake the vial. Always handle with aseptic technique and dispose of used materials properly. Keep out of reach of children and pets.

Avoid Interactions

Alcohol and certain medications may interact with rituximab, potentially affecting its efficacy or increasing side effects. Always inform your healthcare provider about all prescription drugs, over-the-counter medications, and supplements you are taking. Some interactions may require dose adjustments or monitoring.

Frequently Asked Questions

Enfiera 100mg contains rituximab and is used to treat autoimmune diseases like rheumatoid arthritis and certain blood cancers.

Enfiera 100mg is administered as an intravenous infusion under medical supervision in a clinical setting.

Enfiera 100mg is a prescription medication and may be available through licensed online pharmacies with valid prescriptions.

Common effects may include infusion reactions, fatigue, or flu-like symptoms during or after administration.

Store Enfiera 100mg vials refrigerated between 2-8°C and protect from light.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.